Microvillus Inclusion Disease Latest Advances
Find the Latest Research About Microvillus Inclusion Disease
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 204 publications
Long-term clinical trajectory of microvillus inclusion disease associated with STXBP2-related familial hemophagocytic lymphohistiocytosis type 5: A case report.
Journal: JPEN. Journal of parenteral and enteral nutrition
Published: June 20, 2026
Clinical Spectrum, Genetic Profile, and Genotype-Phenotype Correlations in Microvillus Inclusion Disease: A Systematic Review.
Journal: American journal of medical genetics. Part A
Published: April 22, 2026
Microvillus Inclusion Disease: Successful Treatment of Severe Hyponatremia With High-Dose Fludrocortisone via a Possible Gut-Mediated Mechanism.
Journal: ACG case reports journal
Published: August 24, 2025
Microvillus inclusion disease-associated MYO5B deficiency impairs endosome-to-mitochondrion iron transfer.
Journal: Gastroenterology report
Published: August 02, 2025
Myosin 5b deficiency alters liver proliferation, zonation, and bile acid composition.
Journal: Hepatology communications
Published: July 16, 2025
Myosin VB is critical for progenitor cell identity and function in the intestine.
Journal: Stem cell reports
Published: July 10, 2025
LPAR5 as a prospective therapeutic target for treating microvillus inclusion disease.
Journal: Expert opinion on therapeutic targets
Published: April 30, 2025
A liver-specific mouse model for MYO5B-associated cholestasis reveals a toxic gain-of-function as underlying disease mechanism.
Journal: Biochemical and biophysical research communications
Published: March 13, 2025
Odevixibat therapy in progressive familial intrahepatic cholestasis with MYO5B variants: a retrospective case series.
Journal: Orphanet journal of rare diseases
Published: February 06, 2025
Syntaxin 3 regulates apical membrane integrity in proximal tubule epithelial cells and prevents Fanconi syndrome development.
Journal: Kidney international
Published: December 27, 2024
Alterations in cellular metabolic pathway and epithelial cell maturation induced by MYO5B defects are partially reversible by LPAR5 activation.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: October 15, 2024
Microvillus inclusion disease: a short review of literature.
Journal: Gastroenterology and hepatology from bed to bench
Published: October 05, 2024
Last Updated: 11/08/2026